Andlauer Healthcare Group (TSE:AND) and Viemed Healthcare (TSE:VMD) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends and profitability.
Profitability
This table compares Andlauer Healthcare Group and Viemed Healthcare's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Andlauer Healthcare Group | N/A | N/A | N/A |
Viemed Healthcare | N/A | N/A | N/A |
Analyst Recommendations
This is a summary of current ratings and target prices for Andlauer Healthcare Group and Viemed Healthcare, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Andlauer Healthcare Group | 0 | 1 | 1 | 0 | 2.50 |
Viemed Healthcare | 0 | 1 | 0 | 0 | 2.00 |
Andlauer Healthcare Group currently has a consensus price target of C$43.75, suggesting a potential upside of 21.02%. Given Andlauer Healthcare Group's stronger consensus rating and higher possible upside, analysts plainly believe Andlauer Healthcare Group is more favorable than Viemed Healthcare.
Valuation & Earnings
This table compares Andlauer Healthcare Group and Viemed Healthcare's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Andlauer Healthcare Group | C$314.34 million | 4.43 | C$37.59 million | C$0.98 | 37.04 |
Viemed Healthcare | C$131.31 million | 3.57 | C$38.61 million | C$0.98 | 12.13 |
Viemed Healthcare has lower revenue, but higher earnings than Andlauer Healthcare Group. Viemed Healthcare is trading at a lower price-to-earnings ratio than Andlauer Healthcare Group, indicating that it is currently the more affordable of the two stocks.
Summary
Andlauer Healthcare Group beats Viemed Healthcare on 7 of the 8 factors compared between the two stocks.